Spinal muscular atrophies are a heterogeneous group of disorders. They differ in time of onset, clinical presentation, progression, severity and mode of inheritance. In 1985 a Dutch family was described with a dominant, nonprogressive spinal muscular atrophy presenting at birth with arthrogryposis (MIM 600175). Linkage analysis was performed in this family. After having excluded the loci for Werdnig-Hoffmann's disease and for dominant distal spinal muscular atrophy with upper limb predominance, we were able to localise the gene to a 10 cM interval between the markers D12S78 and D12S1646 on chromosome 12q23-q24. Recently, dominant scapuloperoneal spinal muscular atrophy has been localised to an overlapping interval. However, the clinical appearances of scapuloperoneal spinal muscular atrophy and the present disorder make allelism unlikely. In 1994, a second Dutch family with a disorder similar to the present one was described. We excluded linkage to markers of the 12q23-q24 region in this family and thereby proved genetic heterogeneity of this type of dominant, congenital and nonprogressive spinal muscular atrophy.
Introduction
The spinal muscular atrophies (SMAs) are a rather large and heterogeneous group of disorders. [1] [2] [3] [4] [5] [6] [7] [8] The most extensively studied condition in this group is autosomal recessive spinal muscular atrophy type I or Werdnig-Hoffmann's disease. 4 The primary defect in SMA lies in the lower motor neurons or anterior horn cells, which in some cases is shown by autopsy. A subset of SMA presents at birth with contractures and muscle atrophy, 1, 5, 7 suggesting a defect in the development of the anterior horn cells or early degeneration. 5 Therefore, the most likely time of onset is during or shortly after the third month of pregnancy, which is the critical period for differentiation of the spinal motor neurons.
A family with dominant, congenital SMA accompanied by contractures was described by Fleury and Hageman. 5 The condition in this family is nonprogressive and inherited in a dominant pattern. The mildly affected family members suffer from congenital weakness of the distal parts of the lower limbs only. More severely affected individuals show additional weakness of the pelvic girdle and truncal muscles, resulting in scoliosis. Tendon reflexes are absent or reduced and sensory abnormalities are not found. A similar type of dominant SMA has recently been described by Frijns et al. 7 The condition in both families cannot be categorised in the generally accepted classification system of Harding 10 due to its congenital nature. The disorder described by Fleury and Hageman can be uniformly classified as a congenital distal type. In the family described by Frijns et al one of the patients showed involvement of the scapular muscles.
We performed linkage analysis in the family described by Fleury and Hageman. 5 Both the loci for a distal form of dominant spinal muscular atrophy with upper limb predominance on 7p 11 and Werdnig-Hoffmann's disease on 5q12-q13 12, 13 were excluded. We localised the gene for the SMA in the present family to 12q23-q24. The critical region overlaps with the interval between the markers D12S338 and D12S366 in which dominant scapuloperoneal spinal muscular atrophy (SPSMA) is located. 14 The critical region for the present SMA in 12q23-q24 was excluded in the family described by Frijns et al.
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Materials and Methods
Patients
For a detailed description of the patients suffering from the present dominant SMA we refer to the paper of Fleury and Hageman. 5 The authors discriminated four categories of severity. These varied from category one with slight paresis of foot extension and deformities of the feet to category four with paralysis of the distal part of the legs and serious paresis of the muscles of the trunk, the pelvic girdle and the proximal part of the legs. Additional investigations such as electromyography, investigation of motor nerve conduction velocities and muscle and nerve biopsies, showed evidence for a pathology of lower motor neurons. Blood samples were obtained from 20 members of this family, 5 10 of whom were affected. Although individual IV-8 was marked as affected by Fleury and Hageman, reinvestigation did not confirm this. Her tendon reflexes and the strength in her feet are normal. Two non-affected individuals, III-18 and the son of III-20, have been tested for markers derived from the critical region only. From the family described by Frijns et al 7 blood samples were obtained from seven affected members is three generations, two non-affected members and two spouses.
Typing of DNA Markers
DNA was extracted using the method described by Miller et al. 15 Amplification of locus-specific DNA-fragments and their analysis was performed according to Kremer et al. 16 
Statistical Analysis of Linkage Data
Two-point lod scores were calculated, using the subroutine Mlink of the Linkage 5.1 package. [17] [18] [19] A gene frequency of 0.00001 and a penetrance of 100% were assumed for the disorders. Calculations of maximum lod scores were performed using the subroutine Ilink of the Linkage 5.1 package. Multipoint analysis was performed using five-point linkage analysis (Fastlink version 2.30) 20, 21 combined with the sliding window technique.
Results
Linkage to Chromosome 12q23-q24
Linkage analysis was performed in the Dutch family described by Fleury and Hageman (family 1, Figure 1 ). 5 Twenty members of this family were reinvestigated and included in the DNA analysis. Three loci involved in different forms of SMA were regarded as candidates for the present disorder: 7p 11 , 5q12-q13 12,13 and 12q24.1-q24.31.
14 Chromosome 7p harbours a locus for a distal form of SMA. The markers D7S513, D7S493, D7S516, D7S526 and GCK, derived from this locus 11 made this location highly unlikely (Table 1) . Since the proximal border of the critical region was not determined by Christodoulou et al, 11 we tested EGFR and D7S440 which excluded the centromeric region of chromosome 7. The chromosomal region involved in Werdnig-Hoffmann's disease (5q12-q13) was excluded using the polymorphic markers D5S407, D5S629 and D5S118 (Table 1) . Subsequently, an indication for linkage was obtained with the marker D12S79, derived from the critical region described for SPSMA. The maximum lod score was 1.32 at θ = 0.08. The markers D12S366, D12S349 and D12S1639 located distal to D12S79, showed a decrease of the lod score. Therefore, we started our fine mapping with polymorphisms located proximal to D12S79.
Fine Mapping
Nineteen polymorphic markers were tested derived from the region proximal to D12S79. Two-point lod scores between the relevant markers and the disease locus are given in Table 2 . A maximum lod score of 5.16 at θ = 0.00 was obtained with the marker D12S1583. In order to visualise the borders of the critical region haplotypes were constructed (Figure 1 ). The proximal border is determined by a recombination visible in individual III.1 between the markers D12S78 and D12S1342. The marker D12S317 is not informative for this recombination. The distal border of the critical region is determined by a recombination between the markers D12S1583 and D12S1646. Different alleles of the marker D12S1646 co-segregate with the disorder in the two branches of the pedigree. Although the marker D12S1341 is located distal to D12S1646 it has a high lod score which is due to non-informativity of this marker between the two branches of the pedigree (Figure 1 ). Five-point linkage analysis was performed to determine the location of the gene involved with the highest likelihood. A maximum lod score of 5.41 was found in the interval between D12S1339 and D12S1343 and in the interval between D12S1340 and D12S1672 (Figure 2 ). Both these regions are located between D12S1344 and D12S1583.
The SMA in the family described by Frijns et al (family 2), 7 closely resembles the disorder in family 1. Both families originated from the same geographical area. Therefore we analysed family 2 for linkage with markers derived from the interval between D12S78 and D12S354. In Table 3 the two-point lod scores are given. These lod scores exclude the interval determined in family 1.
Discussion
In the present study we localised the gene responsible for congenital distal spinal muscular atrophy in family 1, 5 to an interval of about 10 cM in 12q23-q24, delimited by the markers D12S78 and D12S1646. However, in family 2 linkage to this interval was excluded.
The disorders in family 1 and family 2 7 are clinically very similar (Table 4) . Some of the patients of family 2 show a slight hyperlaxity of the upper limb joints and a mild weakness of the neck flexors. These findings are Interestingly, the locus for the type of spinal muscular atrophy in family 1 has overlap with the locus for SPSMA, 14 which has been mapped to the 19 cM interval between D12S338 and D12S366 (Figure 3) . However, clinically the two disorders are different (Table 4) . At birth, the most remarkable feature of this autosomal dominant form of SPSMA is stridurous breathing due to laryngeal palsy. Lower limb weakness and contractures appear in the first or second decade only, indicating a progressive course of the disease. In contrast, the SMA in family 1 presents with contractures at birth, is limited to the lower extremities and is not progressive. Therefore, allelism of both disorders does not seem very likely. If they are allelic, the critical region for the gene involved is determined by the markers D12S338 and D12S1646. The locus for distal hereditary motor neuropathy type II (distal HMNII) 22 is located distal to the locus for the present SMA and is excluded by the markers D12S366, D12S349 and D12S1639 ( Table 2 ). The locus for autosomal dominant scapuloperoneal muscular dystrophy is located proximal to the locus for the present SMA. 23 There are no very obvious candidate genes known in the critical region of the present disorder. However, a number of genes localised in or around the interval or mapped with overlap to the critical region, can be regarded as candidates. These are, among others: protein phosphatase 1 catalytic gamma isoform (PPP1CC); protein tyrosine phosphatase non-receptor type 11 (PTPN11); nuclear transcription factor Y B-subunit (NFYB); the gene for spinocerebellar ataxia (SCA2) and mitogen activating protein kinase activated protein kinase 2 (MPAKAP kinase2), [24] [25] [26] OMIM. The nitric oxide synthase 1 (NOS1) gene, discussed as a candidate for SPSMA, 14 is located outside the critical region of the present SMA.
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